🧠 AI clinical summary is being generated for this article and will appear shortly.
Source: MHRA · Read original ↗
Idiopathic intracranial hypertension (IIH) has been very rarely reported in patients treated with mesalazine. Following a recent review, warnings for IIH are being added to the product information for all mesalazine products…
This content is sourced from MHRA and reproduced for clinical reference. ClinicalIQ does not alter source content.